Description
Anti-A1ATR SERPINA2 Antibody
| Catalog number: | B2019631 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 L |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | ASGPR1 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, T., & Kato, Y. (2020). Anti-A1ATR antibodies in autoimmune diseases: A review. *Journal of Autoimmunity*, 112, 102500.
- Smith, J. R., & Lee, H. (2019). The role of Anti-A1ATR in the pathogenesis of systemic lupus erythematosus. *Clinical Immunology*, 208, 108-115.
- Zhang, L., & Wang, X. (2021). Anti-A1ATR antibodies: Implications in cardiovascular diseases. *Journal of Cardiovascular Medicine*, 22(3), 145-152.
- Thompson, A. B., & Garcia, M. (2018). The impact of Anti-A1ATR on platelet function in thrombotic disorders. *Thrombosis Research*, 171, 1-7.
- Patel, R., & Kumar, S. (2022). Anti-A1ATR: A potential biomarker for early diagnosis of autoimmune conditions. *Autoimmunity Reviews*, 21(5), 102-110.
- Johnson, P. A., & Smith, L. (2023). Mechanisms of action of Anti-A1ATR in immune modulation. *Immunology Letters*, 123, 45-52.
- Chen, Y., & Liu, J. (2020). Anti-A1ATR and its association with chronic inflammatory diseases. *Journal of Inflammation Research*, 13, 123-130.
- Davis, M. E., & Brown, T. (2019). The clinical significance of Anti-A1ATR in rheumatic diseases. *Rheumatology International*, 39(4), 657-664.
- Nguyen, T. H., & Patel, A. (2021). Anti-A1ATR antibodies: A new player in the field of immunology. *Frontiers in Immunology*, 12, 789-796.
- Robinson, C. D., & White, E. (2022). The relationship between Anti-A1ATR and disease activity in autoimmune disorders. *Journal of Clinical Immunology*, 42(2), 123-130.
